Effects of mefloquine on cardiac contractility and electrical activity in vivo, in isolated cardiac preparations, and in single ventricular myocytes
Effects of mefloquine on cardiac contractility and electrical activity in vivo, in isolated cardiac preparations, and in single ventricular myocytes
复制标题
DOI:
10.1038/sj.bjp.0703060
复制
发表时间:
2000-01-01
影响因子:
7.3
通讯作者:
Eisner, DA
中科院分区:
文献类型:
--
作者:
Coker, SJ;Batey, AJ;Eisner, DA
1 To examine the possible cardiotoxicity of the antimalarial drug mefloquine, increasing doses (0.3-30 mg kg(-1)) were given i.v. to anaesthetized guinea-pigs. Mefloquine did not alter ECG intervals significantly but gradually increased systolic blood pressure (at 3 mg kg(-1)) then had a depressor effect (at 10 mg kg(-1)). Death due to profound hypotension, probably resulting from cardiac contractile failure or AV block, occurred after either 10 mg kg(-1) (2/6) or 30 mg kg(-1) (4/6) mefloquine.2 In isolated cardiac preparations mefloquine (3-100 mu M) did not alter the effective refractory period but at the higher concentrations resting tension increased. Developed tension was reduced by 100 mu M mefloquine in left atria (from 5.8 +/- 1.7 to 2.2 +/- 0.4 mN) whereas in papillary muscles although 30 mu M mefloquine reduced developed tension (from 2.6 +/- 0.5 to 1.1 +/- 0.1 mN) subsequent addition of 100 mu M caused a marked, but not sustained, positive inotropic effect (from 1.2 +/- 0.1 to 3.8 +/- 0.8 mN).3 In single ventricular myocytes, mefloquine (10 mu M) shortened action potential duration (e.g. APD(90) from 285 +/- 29 to 141 +/- 12 ms) and reduced the amplitude of the systolic Ca2+ transient. These effects were accompanied by a decrease in the L-type Ca2+ current.4 These results indicate that the main adverse effect of mefloquine on the heart is a negative inotropic action. This action can be explained by blockade of L-type Ca2+ channels.